clinical trial · NCT07195175
Study of MAR002 in Healthy Men
AcromegalyMAR002Placebo
brief summary
Evaluate the safety and tolerability of subcutaneous (SC) administration of MAR002 in healthy men
started
Aug 11, 2025
primary completion
Jul 1, 2026
completion
Jul 1, 2026
last updated
Jan 12, 2026
official title
First in Human, Randomized, Blinded, Placebo-Controlled Single Ascending Dose and Multiple Dose Study of MAR002 in Healthy Men
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol